94 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Conditions: Cervical Cancer;   Uterine Endometrial Cancer;   Ovarian Cancer
Interventions: Procedure: Laparotomy;   Drug: intravenous narcotics;   Drug: standard anesthesia;   Drug: regional anesthesia;   Drug: Non-steroidal  anti-inflammatory drugs
22 Recruiting Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA
Condition: Recurrent or Persistent Endometrial Carcinoma
Intervention: Drug: Sodium cridanimod
23 Unknown  Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Abdominal total hysterectomy;   Procedure: Robot assisted laparoscopic hysterectomy
24 Recruiting Study Comparing AEZS-108/ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) to Doxorubicin as a Second Line Therapy of Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: AEZS-108 / zoptarelin doxorubicin;   Drug: doxorubicin
25 Unknown  The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients
Condition: Endometrial Cancer
Intervention:
26 Recruiting Phase II Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies
Conditions: Ovarian Carcinoma;   Endometrial Carcinoma;   Cervical Carcinoma
Interventions: Drug: Selinexor Dose A;   Drug: Selinexor Dose B;   Drug: Selinexor Dose C
27 Unknown  Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients
Conditions: Cervical Cancer;   Endometrial Cancer
Intervention: Device: Diffusion weighted MRI (DW- MRI)- Philips Achieva 3.0T X, Netherlands, 2011
28 Recruiting Lymphedema in Endometrial Cancer
Conditions: Lower Extremity Lymphedema;   Endometrial Cancer
Intervention:
29 Recruiting Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.
Conditions: Cervix Cancer;   Endometrium Cancer;   Ovarian Cancer;   Carcinoma in Situ of Fallopian Tube
Intervention: Device: Confocal Laser Endomicroscopy (CLE)
30 Not yet recruiting Phase II Study of Intrauterine Device (IUD) Alone or in Combination With Everolimus in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Device: Levonorgestrel Intrauterine Device (LIUD);   Drug: Everolimus;   Behavioral: Questionnaire
31 Recruiting Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Dasatinib
32 Recruiting Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Conditions: Stage I Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Procedure: lymph node mapping;   Procedure: sentinel lymph node biopsy;   Drug: isosulfan blue;   Drug: indocyanine green solution;   Procedure: therapeutic conventional surgery;   Procedure: lymphadenectomy
33 Unknown  Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Genetic: gene expression analysis;   Other: laboratory biomarker analysis;   Other: medical chart review;   Other: study of socioeconomic and demographic variables
34 Recruiting Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Conditions: Hyperplasia;   Endometrial Cancer
Intervention: Device: Levonorgestrel IUD
35 Recruiting Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
Condition: Stage III-IV or Recurrent Endometrial Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
36 Not yet recruiting Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Conditions: Recurrent Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Intervention: Other: laboratory biomarker analysis
37 Recruiting Assessing the Ultrasound Done on a the Uterus After Hysterectomy as a Diagnostic Tool for the Depth of Endometrial Carcinoma Invasion Into the Myometrium
Condition: Endometrial Endometroid Carcinoma
Intervention: Device: Intraoperative ultrasound
38 Unknown  A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients
Condition: Endometrial Cancer
Intervention: Drug: paclitaxel
39 Recruiting Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Condition: Endometrial Cancer
Interventions: Device: ISB dye and standard white light imaging;   Device: ICG dye and FireFly fluorescence imaging
40 Recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Conditions: Adult Solid Neoplasm;   Bladder Carcinoma;   Breast Carcinoma;   Endometrial Carcinoma;   Esophageal Carcinoma;   Lung Carcinoma;   Malignant Head and Neck Neoplasm;   Melanoma;   Ovarian Neoplasm;   Renal Pelvis and Ureter Urothelial Carcinoma;   Testicular Lymphoma;   Ureter Carcinoma;   Urethral Carcinoma
Interventions: Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Pharmacological Study;   Drug: Veliparib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years